Candidate allergens for inclusion in the Spanish Standard Series based on data from the Spanish Contact Dermatitis Registry

Hernández-Fernández, Carlos Pelayo; García, Pedro Mercader; Salvador, Juan Francisco Silvestre; Pérez, Javier Sánchez; Fernández‐Redondo, Virginia; Miquel, F.J. Miquel; Frutos, F.J. Ortiz de; Gática‐Ortega, María Elena; Fernández, V. Mora; Arnau, A.M. Giménez; Ninet, Violeta Zaragozá; Ortega, Raúl; Sanz‐Sánchez, T.; Nieto, María Dolores; Baldrich, E. Serra; Guijarro, Susana Córdoba; Mendaza, Felipe Heras; González, Isabel Martín; Serna, Mercedes Rodríguez; Garcés, M. Hervella; Descalzo, M.Á.; García‐Doval, I.; Borrego, Leopoldo

doi:10.1016/j.adengl.2021.07.013

Cited by 8 publications

(24 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Results of the GEIDAC obtained with the audit ("candidate") allergens have already been published separately. 13 The audit allergens 1 were tested along with the EBS, that is, in consecutive patients. However, as mentioned, most departments or national groups did not include all audit allergens, and partly not for the entire study period.…”

Section: Resultsmentioning

confidence: 99%

“…Population characteristics according to the MOAHLFA index, 11 extended by the “P‐measure” (the proportion of patients positive to at least one allergen from the baseline series 12 ) are illustrated in Table 1 regarding the subset of patients who were patch tested with at least one audit allergen, which is the focus of the present analysis. Results of the GEIDAC obtained with the audit (“candidate”) allergens have already been published separately 13 …”

Section: Resultsmentioning

confidence: 99%

“…T A B L E 2 Patch test results (day 3 to day 5) with the 2019/20 audit allergens in consecutive patients in the departments of the European Surveillance System on Contact Allergies (ESSCA), additional contributors from the EBS working group, and the contributing GEIDAC members13 Note: Conc., concentration in %, tested in petrolatum. pos., all positive reactions (+, ++, and +++).…”

mentioning

confidence: 99%

See 2 more Smart Citations

European patch test results with audit allergens as candidates for inclusion in the European Baseline Series, 2019/20: Joint results of the ESSCA^A and the EBS^B working groups of the ESCD, and the GEIDAC^C

et al. 2022

Self Cite

View full text Add to dashboard Cite

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

mentioning

confidence: 99%

See 1 more Smart Citation

European patch test results with audit allergens as candidates for inclusion in the European Baseline Series, 2019/20: Joint results of the ESSCA^A and the EBS^B working groups of the ESCD, and the GEIDAC^C

et al. 2022

Self Cite

View full text Add to dashboard Cite

show abstract

“…The GEIDAC is responsible for the definition and publication of the Spanish Baseline Series, the use of which is recommended in all patients patch tested in Spain. During the study period, a particular form with an ‘Extended Spanish Baseline Series’ which includes the European allergens not included in the Spanish series was temporally added to the registry (REIDAC) 4 …”

Section: Methodsmentioning

confidence: 99%

“…During the study period, a particular form with an 'Extended Spanish Baseline Series' which includes the European allergens not included in the Spanish series was temporally added to the registry (REIDAC). 4…”

Section: Geidacmentioning

confidence: 99%

Patch test results with the European baseline series, 2019/20—Joint European results of the ESSCA and the EBS working groups of the ESCD, and the GEIDAC

et al. 2022

Self Cite

View full text Add to dashboard Cite

show abstract

Sensitization to isothiazolinones in the Spanish Contact Dermatitis Registry (REIDAC): 2019–2021 epidemiological situation

et al. 2022

Self Cite

View full text Add to dashboard Cite

Background Current frequency and risk factors for sensitization to methylisothiazolinone (MI), methylchloroisothiazolinone/methylisothiazolinone (MCI/MI), benzisothiazolinone (BIT) and octylisothiazolinone (OIT) in Spain are not well known. Objectives To study the frequency of sensitization, risk factors and simultaneous sensitization between the four isothiazolinones. Materials and Methods We analysed all 2019–2021 consecutive patients patch‐tested with MI (0.2% aq.), MCI/MI (0.02% aq.), BIT (0.1% pet.) and OIT (0.1% pet) within the Spanish Contact Dermatitis Registry (REIDAC). Results A total of 2511 patients were analysed. Frequencies of sensitization were: any isothiazolinone 15.7%, MI 6.8%, MCI/MI 4.8%, BIT 3.5% and OIT 0.5%. MI and MCI/MI sensitization was associated with being occupationally active, hand dermatitis, detergents and age over 40. BIT sensitization was associated with leg dermatitis and age over 40. About one in nine MI‐positive patients were positive to BIT, whereas one in five BIT‐positive patients were positive to MI. Conclusions Sensitization to MI, MCI/MI and BIT is still common in Spain, while sensitization to OIT is rare. Currently, sensitization to MI and MCI/MI seems to be occupationally related. Although its origin is unknown, sensitization to BIT is more frequent in patients aged over 40 years. Simultaneous sensitization between MI and BIT is uncommon.

show abstract

Candidate allergens for inclusion in the Spanish Standard Series based on data from the Spanish Contact Dermatitis Registry

Cited by 8 publications

References 25 publications

European patch test results with audit allergens as candidates for inclusion in the European Baseline Series, 2019/20: Joint results of the ESSCA^A and the EBS^B working groups of the ESCD, and the GEIDAC^C

European patch test results with audit allergens as candidates for inclusion in the European Baseline Series, 2019/20: Joint results of the ESSCA^A and the EBS^B working groups of the ESCD, and the GEIDAC^C

Patch test results with the European baseline series, 2019/20—Joint European results of the ESSCA and the EBS working groups of the ESCD, and the GEIDAC

Sensitization to isothiazolinones in the Spanish Contact Dermatitis Registry (REIDAC): 2019–2021 epidemiological situation

Contact Info

Product

Resources

About

Candidate allergens for inclusion in the Spanish Standard Series based on data from the Spanish Contact Dermatitis Registry

Cited by 8 publications

References 25 publications

European patch test results with audit allergens as candidates for inclusion in the European Baseline Series, 2019/20: Joint results of the ESSCAA and the EBSB working groups of the ESCD, and the GEIDACC

European patch test results with audit allergens as candidates for inclusion in the European Baseline Series, 2019/20: Joint results of the ESSCAA and the EBSB working groups of the ESCD, and the GEIDACC

Patch test results with the European baseline series, 2019/20—Joint European results of the ESSCA and the EBS working groups of the ESCD, and the GEIDAC

Sensitization to isothiazolinones in the Spanish Contact Dermatitis Registry (REIDAC): 2019–2021 epidemiological situation

Contact Info

Product

Resources

About

European patch test results with audit allergens as candidates for inclusion in the European Baseline Series, 2019/20: Joint results of the ESSCA^A and the EBS^B working groups of the ESCD, and the GEIDAC^C

European patch test results with audit allergens as candidates for inclusion in the European Baseline Series, 2019/20: Joint results of the ESSCA^A and the EBS^B working groups of the ESCD, and the GEIDAC^C